Table S2 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium | Synapse
February 8, 2024Open Access
Table S2 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Demographics and details of treatment in patients who continued ICI progression (n=38)